Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jun 30, 2026
TickeronGET DAILY SIGNALS
Concentrix (CNXC) Delivers Q2 Results in Line with Guidance, Shares Decline Despite iX Suite Gains

Concentrix (CNXC) Delivers Q2 Results in Line with Guidance, Shares Decline Despite iX Suite Gains

Key Takeaways

  • Revenue reached $2.46 billion, up 1.9% year-over-year and within the guided range of $2.46 billion to $2.485 billion.
  • GAAP diluted EPS rose to $0.86 from $0.63 in the prior-year quarter.
  • Non-GAAP diluted EPS of $2.63 fell slightly year-over-year but stayed inside the expected $2.57 to $2.69 range.
  • Constant currency revenue grew 0.6% year-over-year.
  • iX Suite deals increased 400% year-over-year, highlighting momentum in AI-driven solutions.
  • Shares declined sharply following the release despite results meeting expectations.

Earnings Context and Why It Matters

Concentrix Corporation provides customer experience solutions and technology services to global brands. Its fiscal second quarter, ended May 31, 2026, offered insight into demand trends in a competitive business process outsourcing and digital transformation market. Investors monitor these results for signs of sustained revenue growth, margin stability, and progress on AI initiatives such as the iX Suite, which can influence long-term positioning and cash generation.

Reported Results

Concentrix reported revenue of $2,462.5 million for the second quarter of fiscal 2026, compared with $2,417.4 million a year earlier. GAAP diluted earnings per share increased to $0.86 from $0.63. Non-GAAP diluted earnings per share came in at $2.63 versus $2.70 previously. Both revenue and non-GAAP EPS landed within company guidance. Revenue grew 0.6% on a constant currency basis. The company highlighted a 400% year-over-year rise in iX Suite deals as a key operating highlight. From what I see, the steady top-line performance and AI momentum stand out even as non-GAAP earnings edged lower.

Market Reaction and Investor Sentiment

Shares of CNXC fell sharply after the June 29, 2026, release despite results aligning with guidance. The reaction reflected investor caution around the modest year-over-year decline in non-GAAP earnings per share and broader sector sentiment. Analysts noted that revenue growth remained modest while AI-related deal momentum provided a positive offset. I’m watching this closely because the disconnect between in-line results and the price action often signals near-term uncertainty around growth sustainability.

Forward Outlook and Key Factors to Monitor

Investors will focus on the pace of constant currency revenue growth and the contribution from higher-margin AI offerings in coming quarters. Management guidance for the full year and any updates on operating margins will provide additional context. Demand signals from large enterprise clients, foreign exchange impacts, and progress on cost management remain relevant. The company’s ability to convert iX Suite momentum into sustained revenue expansion could influence future performance.

Upcoming catalysts include potential client wins in digital transformation and any commentary on macroeconomic conditions affecting outsourcing budgets. Margin trends and cash flow generation will also warrant attention as the company navigates a competitive environment.

AI Tools in My Research Process

I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CNXC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CNXC's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CNXC turned positive on November 10, 2026. Looking at past instances where CNXC's MACD turned positive, the stock continued to rise in 32 of 42 cases over the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on CNXC as a result. In 59 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

CNXC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CNXC crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

The 50-day moving average for CNXC moved above the 200-day moving average on October 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +4.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNXC advanced for three days, in 207 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 140 of 196 cases where CNXC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Bearish Trend Analysis

The 10-day RSI Indicator for CNXC moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNXC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

CNXC broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.685) is normal, around the industry mean (2.898). P/E Ratio (-1.455) is within average values for comparable stocks, (18.492). Projected Growth (PEG Ratio) (0.323) is also within normal values, averaging (2.284). Dividend Yield (0.049) settles around the average of (0.224) among similar stocks. P/S Ratio (0.180) is also within normal values, averaging (139.965).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. CNXC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNXC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 10.39B. The market cap for tickers in the group ranges from 100 to 230.82B. IBM holds the highest valuation in this group at 230.82B. The lowest valued company is ARSC at 100.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 3%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -8%. TTEC experienced the highest price growth at 100%, while HLSQ experienced the biggest fall at -42%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was -48%. For the same stocks of the Industry, the average monthly volume growth was -41% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 55
Price Growth Rating: 60
SMR Rating: 74
Profit Risk Rating: 93
Seasonality Score: 20 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of active thermal coal operations

Industry InformationTechnologyServices

Industry
Coal
Address
39899 Balentine Drive
Phone
+1 800 747-0583
Employees
455000
Web
https://www.concentrix.com
Interact to see
Advertisement
BZ dropped sharply, sliding from a $16.72 prior close to $13.48 (-19.38%), with the decline beginning in premarket and deepening into the early regular session. No verified company-specific news or fundamental catalyst was issued; the fall tracked a broad China ADR selloff (the Nasdaq Golden Dragon index slid more than 2%), but that alone is too small to explain a ~20% drop — the stock's Hong Kong listing fell only -2.6%.
Nebius Group N.V. is expected to report third-quarter 2026 results in early November, following a second quarter in which revenue surged 454% year over year. Wall Street consensus tracked by Benzinga points to roughly $937 million in Q3 2026 revenue, up from $146.1 million in the year-ago quarter.
The $1.14 central target is not an analyst consensus; it is the all-cash merger consideration in GoPro, Inc. (GPRO) 's pending deal with Starman Optical, agreed in September 2026. With the stock trading near $0.88, reaching $1.14 would require a move of roughly 29.5%.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.